Australia markets close in 4 hours 28 minutes

Sichuan Hebang Biotechnology Corporation Limited (603077.SS)

Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
2.1200-0.0300 (-1.40%)
As of 09:25AM CST. Market open.
Currency in CNY

Valuation measures4

Market cap (intra-day) 18.72B
Enterprise value 18.92B
Trailing P/E 20.09
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.16
Price/book (mrq)0.98
Enterprise value/revenue 2.24
Enterprise value/EBITDA 16.75

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3-20.60%
S&P500 52-week change 325.59%
52-week high 32.7100
52-week low 31.9300
50-day moving average 32.3200
200-day moving average 32.3661

Share statistics

Avg vol (3-month) 376.29M
Avg vol (10-day) 3131.17M
Shares outstanding 58.83B
Implied shares outstanding 68.87B
Float 84.9B
% held by insiders 138.46%
% held by institutions 12.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.05
Forward annual dividend yield 42.12%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 442.65%
Dividend date 3N/A
Ex-dividend date 407 June 2023
Last split factor 222:10
Last split date 305 July 2017

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 10.87%
Operating margin (ttm)2.43%

Management effectiveness

Return on assets (ttm)2.50%
Return on equity (ttm)4.64%

Income statement

Revenue (ttm)8.43B
Revenue per share (ttm)0.98
Quarterly revenue growth (yoy)-16.50%
Gross profit (ttm)N/A
EBITDA 2B
Net income avi to common (ttm)916.48M
Diluted EPS (ttm)0.1100
Quarterly earnings growth (yoy)-92.50%

Balance sheet

Total cash (mrq)2.78B
Total cash per share (mrq)0.34
Total debt (mrq)2.98B
Total debt/equity (mrq)15.16%
Current ratio (mrq)2.12
Book value per share (mrq)2.30

Cash flow statement

Operating cash flow (ttm)-700.47M
Levered free cash flow (ttm)-1.51B